Author

Thomas Dillinger

Ludwig Boltzmann Institute Applied Diagnostics

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:organoid / primary culture· 1

Frequent Co-Authors

Andreas TiefenbacheriD· 1 shared Anil Baskan· 1 shared Emine Atas· 1 shared Gabriel WasingeriD· 1 shared Gerda EggeriD· 1 shared Jessica KallaiD· 1 shared Katarina MišuraiD· 1 shared Kristina DraganićiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andreas TiefenbacherORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Biobank of genetically defined murine prostate cancer tumoroids uncovers oncogenic pathways and drug vulnerabilities driven by PTEN-loss

Jessica Kalla, Thomas Dillinger, Zlata Pavlovicova, Reema Jacob, Emine Atas, Katarina Mišura, Anil Baskan, Kristina Draganić, Andreas Tiefenbacher, Tanja Limberger, Theresia Mair, Gabriel Wasinger, Ludovica Villanti, Stefan Kubicek, Lukas Kenner, Gerda Egger

This study establishes a murine tumoroid biobank to identify oncogenic pathways and drug vulnerabilities in prostate cancer, finding that PTEN loss drives cancer pathways and that specific compounds inhibit tumor growth.

Cell Reports Methods · Mar 30, 2026Peer-reviewedCancer Biology